Human Health
U of T Engineering is a leader in health care engineering. Together with doctors, medical researchers, policymakers and industry, we are helping people around the world live longer, healthier lives.
To enable future success in the evolving bioproducts industry, we developed specialized programs to teach students to translate their bioengineeiring research into successful startups.
- Brain-Machine Interfacing
- Cell Manufacturing
- Disease Modeling & Therapeutics
- Health-care Engineering
- Heart Research
- Next-generation Medical Devices
- Regenerative Medicine
- Synthetic Biology
Medicine by Design undertakes transformative research in regenerative medicine and cell therapy.
Translational Biology and Engineering Program
TBEP drives research at the interface of engineering and medicine. With a roster of multidisciplinary investigators, researchers develop strategies that will repair or regenerate heart muscle.
Centre for Healthcare Engineering
CHE is a leader in interdisciplinary research and education in healthcare engineering. Its research directly impacts healthcare organizations and partners in practice.
Southern Ontario Centre for Atmospheric Aerosol Research
SOCAAR is a world-class centre for environmental research committed to innovation in producing a broad, trans-disciplinary and actionable understanding of the origins, characteristics, environmental impact, and human health consequences of atmospheric aerosols.
Study Human Health at U of T Engineering
The Institute of Biomaterials & Biomedical Engineering (IBBME) — a multidisciplinary research community of engineering, medicine and dentistry investigators — offers research-based graduate programs at both the Master’s and Doctoral levels, as well as a Master of Health Science (MHSc) in Clinical Engineering and a Master of Engineering (MEng) that focuses on the design of biomedical devices. At the undergraduate level, engineering students can minor in Biomedical Engineering or Bioengineering, and Engineering Science students can major in Biomedical Systems Engineering.
Leading innovation starts here
Connect with our partnerships team to discuss how a partnership with U of T Engineering can benefit your organization.
Researchers at the University of Toronto’s Faculty of Applied Science & Engineering have designed a new microfluidic platform that allows for unprecedented control and manipulation of tumor shapes — a largely unexplored area with great potential to advance cancer research.
The work, led by Professor Edmond Young (MIE, BME), offers new insights into how the shape of tumours can predict cancer cell behaviour and aggressiveness, which opens new pathways for more personalized and targeted cancer care.
“While there are several platforms for in vitro modelling of spheroids — three-dimensional aggregates of cells that can mimic tissues and mini tumours — a challenge in the cancer research field has been the inability to control the shape, recovery and location of these cancer organoids,” says Sina Kheiri (MIE PhD 2T4), the co-lead author of the study, which was recently published in Advanced Materials.
“So, researchers end up with these tumours-on-a-chip that can’t be easily characterized because they are stuck on the device and can only be observed through optical microscopy.”
The new platform, called Recoverable-Spheroid-on-a-Chip with Unrestricted External Shape (ReSCUE), gives researchers the ability to recover and release tumoroids to perform downstream analysis and characterization.
The platform also enables researchers to grow cancer organoids in any shape they want